Morgan Stanley Call 107.5 GXI 21..../ DE000MG2F0V5 /
05/06/2024 11:27:47 | Var.+0.02 | Denaro13:30:24 | Lettera13:30:24 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
2.48EUR | +0.81% | 2.57 Quantità in denaro: 40,000 |
2.64 Quantità in lettera: 40,000 |
GERRESHEIMER AG | 107.50 EUR | 21/03/2025 | Call |
GlobeNewswire
13:35
Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories
Newsfile Corp
13:30
Appia Begins Uranium Exploration Season with Ground Reconnaissance at "Eastside" Project, Saskatchew...
GlobeNewswire
13:30
Hydreight in Partnership with DSV Global and VS Digital Health Launches Telemedicine Solution That H...
GlobeNewswire
13:30
Ocean Power Technologies Awarded Contract for Immediate Delivery of Unmanned Surface Vehicle to Offs...
GlobeNewswire
13:30
Bread Financial™ to Participate in the Morgan Stanley U.S. Financials, Payments & Commercial Real Es...
GlobeNewswire
13:30
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
13:28
Ollie’s Bargain Outlet Announces Executive Promotions and Appointments as Part of Anticipated Leader...
GlobeNewswire
13:05
Eldorado Gold Announces Election of Directors and Voting Results from Annual Meeting of Shareholders
GlobeNewswire
13:05
Y-mAbs Deepens Radiopharmaceutical Leadership with Appointment of Norman LaFrance, M.D. as Chief Dev...
GlobeNewswire
13:01
Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positiv...
GlobeNewswire
13:00
SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conferenc...
GlobeNewswire
13:00
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)